Clinical Chemistry, Malmö
441 – 450 of 1293
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels: modification by adiposity in nondiabetic subjects
(
- Contribution to journal › Published meeting abstract
-
Mark
Prostate-specific Antigen/Solvent Interaction Analysis: A Preliminary Evaluation of a New Assay Concept for Detecting Prostate Cancer Using Urinary Samples EDITORIAL COMMENT
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
(
- Contribution to journal › Article
-
Mark
Activated protein C cofactor function of protein S: a novel role for a gamma-carboxyglutamic acid residue
(
- Contribution to journal › Article
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects
(
- Contribution to journal › Letter
-
Mark
Regulation of cysteinyl leukotriene receptor 2 expression-a potential anti-tumor mechanism.
(
- Contribution to journal › Article
-
Mark
Age and gender differences in the association between Nt-proBNP and glucometabolic disturbances.
(
- Contribution to journal › Article
-
Mark
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
(
- Contribution to journal › Article
-
Mark
Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency.
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article